Medications

FDA approves Ogsiveo for desmoid tumors

The U.S. Food and Drug Administration has approved SpringWorks Therapeutics Inc.'s Ogsiveo (nirogacestat) tablets for adult patients with progressing desmoid tumors who require systemic treatment.

page 6 from 40